INS and Dengue hemorrhagic fever: Our findings suggest that patients using insulin (p = 0.003), GLP1 RA (p = 0.023) or both associated (p = 0.007) were exposed to a higher risk of DHF at admission, while patients using sulfonylureas (p = 0.009), metformin and DPP4i association (p = 0.029) and metformin and sulfonylurea association (p = 0.003) to a lower risk (Table 3).